These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6140010)

  • 21. Tyrosine hydroxylase regulation: apparent kinetic alterations following incubation of brain slices in a sodium-free medium.
    Bustos G; Simon J; Roth RH
    J Neurochem; 1980 Jul; 35(1):47-57. PubMed ID: 6108991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stimulation of rat striatal tyrosine hydroxylase by phospholipids and adenosine-3',5'-monophosphate.
    Raese J; Patrick RL; Barchas JD
    Arzneimittelforschung; 1976; 26(6):1107-9. PubMed ID: 9109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular mechanisms in the actions of morphine and viminol (R2) on rat striatum.
    Carenzi A; Guidotti A; Revuelta A; Costa E
    J Pharmacol Exp Ther; 1975 Aug; 194(2):311-8. PubMed ID: 239224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclic AMP content and regulation of tyrosine-3-mono-oxygenase in rat striatum.
    Zivkovic B; Guidotti A; Costa E
    J Cyclic Nucleotide Res; 1976; 2(1):1-10. PubMed ID: 5470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stimulation of tyrosine hydroxylase activity by cyclic AMP in synaptosomes and in soluble striatal enzyme preparations.
    Goldstein M; Bronaugh RL; Ebstein B; Roberge C
    Brain Res; 1976 Jun; 109(3):563-74. PubMed ID: 6124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tyrosine hydroxylase in the stalk-median eminence and posterior pituitary is inactivated only during the plateau phase of the preovulatory prolactin surge.
    Arbogast LA; Ben-Jonathan N
    Endocrinology; 1989 Aug; 125(2):667-74. PubMed ID: 2568925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tyrosine hydroxylase from bovine striatum: catalytic properties of the phosphorylated and nonphosphorylated forms of the purified enzyme.
    Lazar MA; Lockfeld AJ; Truscott RJ; Barchas JD
    J Neurochem; 1982 Aug; 39(2):409-22. PubMed ID: 6123557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of tyrosine hydroxylase from human pheochromocytoma, bovine adrenal and rat striatum.
    Simon JR; Hegstrand LR; Roth RH
    Life Sci; 1978 Feb; 22(5):421-8. PubMed ID: 25366
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effects of S-adenosylmethionine and S-adenosylhomocysteine on in vivo synthesis of noradrenaline and serotonin in different parts of the rat brain].
    Fonlupt P; Barailler J; Roche M; Cronenberger L; Pacheco H
    C R Seances Acad Sci D; 1979 Jan; 288(2):283-6. PubMed ID: 111855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The regulation of striatal tyrosine hydroxylase. Effects of gamma hydroxybutric acid and healperidol.
    Zivkovic B; Guidotti A; Costa E
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 291(2):193-200. PubMed ID: 629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes of kinetic constant of striatal tyrosine hydroxylase elicited by neuroleptics that impair the function of dopamine receptors.
    Zivkovic B; Guidotti A
    Brain Res; 1974 Oct; 79(3):505-9. PubMed ID: 4153770
    [No Abstract]   [Full Text] [Related]  

  • 32. Evidence for a role of nigral gamma-aminobutyric acid and substance P in the haloperidol-induced activation of striatal tyrosine hydroxylase.
    Gale K; Costa E; Toffano G; Hong JS; Guidotti A
    J Pharmacol Exp Ther; 1978 Jul; 206(1):29-37. PubMed ID: 26799
    [No Abstract]   [Full Text] [Related]  

  • 33. The effects of S-adenosylhomocysteine and S-adenosylmethionine on some purine- and pyrimidine-metabolizing systems.
    Tudball N
    Biosci Rep; 1982 Oct; 2(10):769-75. PubMed ID: 6293601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation by the ratio S-adenosylmethionine/S-adenosylhomocysteine of cyclic AMP-dependent phosphorylation of the 50 kDa protein of rat liver phospholipid methyltransferase.
    Villalba M; Varela I; Mérida I; Pajares MA; Martínez del Pozo A; Mato JM
    Biochim Biophys Acta; 1985 Dec; 847(3):273-9. PubMed ID: 2998482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Destruction of post-synaptic dopamine receptors prevents neuroleptic-induced activation of striatal tyrosine hydroxylase but not dopamine synthesis stimulation.
    Di Chiara G; Onali PL; Tissari AH; Porceddu ML; Morelli M; Gessa GL
    Life Sci; 1978 Aug; 23(7):691-6. PubMed ID: 29204
    [No Abstract]   [Full Text] [Related]  

  • 36. Reversible conversion of tyrosine hydroxylase to an inactive form by antipain.
    Okuno S; Fujisawa H
    Biochem Biophys Res Commun; 1987 Aug; 146(3):1375-81. PubMed ID: 2887168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tyrosine hydroxylase activation and inactivation by protein phosphorylation conditions.
    Vrana KE; Allhiser CL; Roskoski R
    J Neurochem; 1981 Jan; 36(1):92-100. PubMed ID: 6109760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inactivation of tyrosine hydroxylase activity by ascorbate in vitro and in rat PC12 cells.
    Wilgus H; Roskoski R
    J Neurochem; 1988 Oct; 51(4):1232-9. PubMed ID: 2901463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic haloperidol: tolerance to the stimulating effect on striatal tyrosine hydroxylase.
    Tissari AH; Casu M; Gessa GL
    Life Sci; 1979 Jan; 24(5):411-6. PubMed ID: 34768
    [No Abstract]   [Full Text] [Related]  

  • 40. Purification and characterization of rat striatal tyrosine hydroxylase. Comparison of the activation by cyclic AMP-dependent phosphorylation and by other effectors.
    Richtand NM; Inagami T; Misono K; Kuczenski R
    J Biol Chem; 1985 Jul; 260(14):8465-73. PubMed ID: 2861203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.